Approval · Notice of Compliance 31375 · 2023
HALOPERIDOL INJECTION: Notice of Compliance 31375
Issued August 4, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31375
- Date
- August 4, 2023
- Company
- Juno Pharmaceuticals Corp.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Manufacturers
- Canadian reference product
- HALOPERIDOL INJECTION USP (Sandoz Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HALOPERIDOL INJECTION | 02540223 | Cancelled Pre Market |
Medicinal ingredients
- HALOPERIDOL 5 MG per ML